STOCK TITAN

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Avadel Pharmaceuticals plc (AVDL) will participate in upcoming investor conferences to discuss their biopharmaceutical endeavors. The company aims to transform medicines and lives through its innovative approach.
Positive
  • None.
Negative
  • None.

DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:

  • Leerink Global Biopharma Conference: Fireside chat on Monday, March 11 at 3:20 p.m. ET.
  • UBS Virtual CNS Day: Fireside chat on Monday, March 18 at 12:30 p.m. ET.

A live webcast of these events, as well as an archived recordings, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following each conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Mogerley
Stern Investor Relations, Inc.
Courtney.Mogerley@sternir.com
(212) 698-8687

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162


Avadel Pharmaceuticals plc (AVDL) will have a fireside chat at the Leerink Global Biopharma Conference on Monday, March 11 at 3:20 p.m. ET.

Avadel Pharmaceuticals plc (AVDL) will have a fireside chat at the UBS Virtual CNS Day on Monday, March 18 at 12:30 p.m. ET.

Investors can access the live webcast and archived recordings of Avadel Pharmaceuticals plc (AVDL) events on the company's Investor Relations website, investors.avadel.com, for 90 days after each conference.
Avadel Pharmaceuticals plc

NASDAQ:AVDL

AVDL Rankings

AVDL Latest News

AVDL Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Medicinal and Botanical Manufacturing
Ireland
Dublin

About AVDL

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.